Aripiprazole-Associated Rhabdomyolysis in a 17-Year-Old Male

dc.authoridYazan Songur, Cisel/0000-0003-3450-1236
dc.authoridApa, Hursit/0000-0002-0601-4679
dc.contributor.authorKutlu, Ayse
dc.contributor.authorSongur, Cisel Yazan
dc.contributor.authorApa, Hursit
dc.date.accessioned2025-03-26T17:34:45Z
dc.date.available2025-03-26T17:34:45Z
dc.date.issued2023
dc.departmentİstanbul Esenyurt Üniversitesi
dc.description.abstractRhabdomyolysis is a rare serious side effect of antipsychotic medication use. There are cases of rhabdomyolysis due to the use of clozapine, risperidone, olanzapine, and haloperidol in the literature. In this report, we describe a rhabdomyolysis case developed on the 13th day of using 2.5 mg /day aripiprazole in a 17-year-old male patient with a diagnosis of somatic symptom disorder. This case is one of the youngest in the literature to develop rhabdomyolysis after the use of aripiprazole. Moreover, this case is distinguished from the others with its low-dose, short-term and single antipsychotic use. In the child and adolescent age group, routine blood tests should be done before starting medication. Symptoms that appear to be nonspecific and that may be overlooked or may be thought to be caused by an existing psychiatric complaint should be carefully and thoroughly considered during follow-up.
dc.identifier.doi10.34172/aim.2023.08
dc.identifier.endpage53
dc.identifier.issn1029-2977
dc.identifier.issn1735-3947
dc.identifier.issue1
dc.identifier.pmid37543922
dc.identifier.scopus2-s2.0-85164814022
dc.identifier.scopusqualityQ1
dc.identifier.startpage50
dc.identifier.urihttps://doi.org/10.34172/aim.2023.08
dc.identifier.urihttps://hdl.handle.net/20.500.14704/875
dc.identifier.volume26
dc.identifier.wosWOS:000993065400008
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherAcad Medical Sciences I R Iran
dc.relation.ispartofArchives of Iranian Medicine
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20250326
dc.subjectAripiprazole; Atypical antipsychotics; Case report; Rhabdomyolysis
dc.titleAripiprazole-Associated Rhabdomyolysis in a 17-Year-Old Male
dc.typeArticle

Dosyalar